Ethical challenges to the integrity of Physicans: Financial conflicts of interest in clinical research

Accountability in Research

Volumn 11, Issue 2, 2004, Pages 119-139

  Solyom, Antal E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CONFLICT OF INTEREST; ECONOMICS; ETHICS; HUMAN EXPERIMENT; HUMAN RELATION; INDUSTRY; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICAL SOCIETY; MOTIVATION; PHYSICIAN; PUBLIC RELATIONS; UNITED STATES; UNIVERSITY;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

AMERICAN MEDICAL ASSOCIATION; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; ETHICS, MEDICAL; HUMAN EXPERIMENTATION; INDUSTRY; INTERINSTITUTIONAL RELATIONS; MOTIVATION; PHYSICIANS; RESEARCHER-SUBJECT RELATIONS; UNITED STATES; UNIVERSITIES;

EID: 15844393517     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/03050620490512313     Document Type: Article

References (41)

1. American Medical Association (AMA). (2002a). A Declaration of Professional Responsibility: Medicine's Social Contract with Humanity. Annual Meeting, June.
2. American Medical Association (AMA). (2002b). Code of Medical Ethics. Washington, DC: AMA Press.
3. Arras, J. D. (2001). A method in search of a purpose: The internal morality of medicine. Journal of Medicine and Philosophy 26:643-662.
4. Ashley, B. M. and O'Rourke, K. D. (2002). Ethics of Health Care. An Introductory Textbook (3rd edition). Washington, DC: Georgetown University Press.
5. Beach, J. E. (2002). Clinical trials integrity: A CRO perspective. In Business and Research, edited by Shamoo, A. E. and Moreno, J. New York: Taylor & Francis.
6. Beecher, H. K. (1966). Ethics and clinical research. New England Journal of Medicine, 74: 1354-1360.
7. Birch, D. M., and Cohn, G. (2001). Series: Of patients and profits. The Baltimore Sun, 24-26 June.
8. Bodenheimer, T. (2000). Uneasy alliance. Clinical investigators and the pharmaceutical industry. New England Journal of Medicine 342:1539-1544.
9. Boyd, E. A., Cho, M. K., and Bero, L. A. (2003). Financial conflict-of-interest policies in clinical research: Issues for clinical investigators. Academic Medicine 78, 8:769-774.
10. Brody, B. (1995). Ethical Issues in Drug Testing, Approval, and Pricing. New York: Oxford University Press.
11. Brody, B. (1996). Conflicts of interest and validity of clinical trials. In Conflicts of Interests in Clinical Practice and Research, edited by R. Spece, D. Schimm, and A. Buchanan. New York: Oxford University Press.
12. Campbell, E. G., Weissman, J. S., Clarridge, B., Yucell, R. Causino, N. and Blumenthal, D. (2003). Characteristics of medical school faculty members serving on Institutional Review Boards: Results of a national survey. Academic Medicine 78, 8:831-836.
13. Dana, J. and Loewenstein, G. (2003). A social science perspective on gifts to physicians from industry. Journal of the American Medical Association 290:252-255.
14. Dell'Oro, R. (2002). The market ethos and the integrity of health care. The Journal of Contemporary Health Law and Policy 18:641-647.
15. Emanuel, E. J., and Steiner, D. (1995). Institutional conflict of interest. New England Journal of Medicine 332:262-267.
16. Emanuel, E. J., Wendler, D., and Grady, C. (2000). What makes clinical research ethical? Journal of the American Medical Association 283:1701-1710.
17. Erde, E. L. (1996). Conflicts of interests in medicine: A philosophical and ethical morphology. In Conflicts of Interests in Clinical Practice and Research, edited by R. Spece, D. Schimm, and A. Buchanan. New York: Oxford University Press.
18. Freedman, B., K. C. Glass, and C. Weijer (1996). Placebo orthodoxy in clinical research. II: Ethical, legal, and regulatory myths. Journal of Law, Medicine & Ethics 24:252-259.
19. Frankel, M. S. (1996). Perception, reality and the political context of conflict of interest in university-industry relationships. Academic Medicine 71:1297-1304.
20. Heyd, D. (1996). Experimentation on trial: Why should one take part in medical research? Jahrbuch für Recht und Ethik 4:189-204.
21. Institute of Medicine, National Research Council. (2002). Integrity in Scientific Research: Creating an Environment That Promotes Responsible Conduct. Washington, DC: National Academic Press.
22. Johansen, H. K., and Gotzsche, P. C. (1999). Problem in the design and reporting of trials of antifungal agents encountered during meta-analysis. Journal of the American Medical Association 282:1752-1759.
23. Jonas, H. (1969). Philosophical reflections on experimenting with human subjects. Daedalus 98:219-247.
24. Katz, D., Caplan, A. L., and Merz, J. F. (2003). All gifts large and small. Toward an understanding of the ethics of pharmaceutical industry gift-giving. The American Journal of Bioethics 3, 3:39-46.
25. Klaidman, S. (2002). Conflict of interest in cardiac medicine. In Business and Research edited by A. E. Shamoo, and J. Moreno. New York: Taylor & Francis.
26. Klein, J. E., and Fleischman A. R. (2002). The private practicing hysician-investigator: Ethical implications of clinical research in the office setting. Hastings Center Report 32, 4:22-26.
27. Ladd, J. (1983). Internal morality of medicine: An essential dimension of the patientphysician relationship. In The Clinical Encounter, edited by E. Shelp. Boston, MA: D. Reidel. 209-232.
28. Madsen, S., Holm, S., and Riis, P. (1999). Ethical aspects of clinical trials: The attitudes of the public and out-patients. Journal of Internal Medicine 245:571-579.
29. Miller, F. G., Rosenstein, D. L., and DeRenzo, E. G. (1998). Professional integrity in clinical research. Journal of the American Medical Association 280:1449-1454.
30. Morin, K., et al. (2002). Managing conflict of interest in the conduct of clinical trials. Journal of the American Medical Association 287: 78-84.
31. Pellegrino, E. D. (1999). The goal and ends of medicine: How are they to be defined? In The Goals of Medicine: The Forgotten Issue in Health Care Reform, edited by M. J. Hanson and D. Callahan. Washington, D.C.: Georgetown University Press. pp. 55-68.
32. Ramsey, P. (1970). The Patient as Person. New Haven, CT: Yale University Press.
33. Shamoo, A. E. (2002). Adverse events reporting-The tip of an iceberg. In Business and Research, edited by A. E. Shamoo, and J. Moreno. New York: Taylor & Francis.
34. Solyom, A. E. (2004a). Leadership responsibilities and integrity of physicians in healthcare. Medscape General Medicine, 6, 1. [www.medscape.com/viewarticle/471135]
35. Solyom, A. E. (2004b). Omitted considerations and populations: A response to "Should children decide whether they are enrolled in nonbeneficial research?" by David Wendler and Seema Shah (AJOB 3:4). American Journal of Bioethics 4, 1: W 39.
36. Stolberg, S. G. (2000). Teenager's death is shaking up field of human gene-therapy experiments. New York Times, 27 January.
37. Sung, N. S., et al. (2003). Central challenges facing the national clinical research enterprise. Journal of the American Medical Association 289:1278-1289.
38. Tereskerz, P. M. (2003). Research accountability and financial conflicts of interest in industry-sponsored clinical research: A review. Accountability in Research 10:137-158.
39. Thompson, D. F. (1993). Understanding financial conflicts of interests. New England Journal of Medicine 329:573-576.
40. Veatch, R. M. (1987). The Patient As Partner. A Theory of Human-Experimentation Ethics. Bloomington and Indianapolis: Indiana University Press.
41. Whitaker, R. (2002). The ethics of reporting research results accurately. In Business and Research, edited by A. E. Shamoo, and J. Moreno. New York: Taylor & Francis.